CBD is not converted to THC in rats: A framework interpretation and discussion

Varování

Publikace nespadá pod Fakultu sportovních studií, ale pod Lékařskou fakultu. Oficiální stránka publikace je na webu muni.cz.

Autoři	VACEK Jan PAPOUSKOVA Barbora HOLCOVÁ POLANSKÁ Hana HÖNIGOVÁ Kateřina STORCH Jan BABULA Petr MASAŘÍK Michal
Rok publikování	2021
Druh	Článek v odborném periodiku
Časopis / Zdroj	European Neuropsychopharmacology
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://www.sciencedirect.com/science/article/pii/S0924977X21001917?via%3Dihub
Doi	http://dx.doi.org/10.1016/j.euroneuro.2021.04.003
Klíčová slova	CBD; THC; rats
Popis	Cannabidiol (CBD) is a non-psychotropic exogenous cannabinoid that is an active component in a number of topical and oral preparations. The pharmacological potential of CBD is determined by its anti-inflammatory and immuno- or neuromodulatory activities. This natural terpenoid is widely used today, and therefore more attention is now paid to examining its safety after the administration of high doses (Epidiolex) and also after low-dose chronic exposure, e.g. in the form of food supplements. CBD is therefore a molecule that has recently gained a great deal of scientific interest, both at the level of basic research and industrial development.